Suxiang John Chen Dr

Honorary Research Fellow, Personalised Medicine Centre, Health Futures Institute, Murdoch University

Other Open access

Antisense therapy for PTP1B related conditions

by R.N. Veedu and S. Chen

Published 2020

Patent. WRAYS PTY LTD, WO/2020/077390

An isolated or purified antisense oligomer targeted to a nucleic acid molecule encoding PTPN1 pre-mRNA, wherein the antisense oligomer inhibits the expression of PTP1B.

Suxiang John Chen Dr

Honorary Research Fellow, Personalised Medicine Centre, Health Futures Institute, Murdoch University

Output list